Welcome to the Division of Hematology & Hematologic Malignancies!

The scientific focus of our division is the study of blood and bone marrow in health and disease. Our physicians treat patients with blood cancer, such as leukemias and lymphomas, clotting disorders, such as hemophilia, and diseases of iron metabolism, such as hemochromatosis.

Starting with Maxwell Wintrobe, one of the founding fathers of hematology and the University of Utah Medical School, our division can look back at a long-standing tradition of excellence in research, clinical care, and teaching. Last year researchers from our division garnered more than $7,000,000 in grant income, presented their data at major conferences and published their results in prime international journals. This would not be possible without the University of Utah’s outstanding collaborative environment and its strong scientific foundation.

Our goal is to translate our scientific discoveries into improved care for our patients. We believe that every patient is unique and requires an individualized approach to achieve the best possible outcome. And we believe that the key to this is to better understand diseases at the molecular level. As we strive to accomplish this goal  we are expanding our clinical services to make the latest scientific discoveries available to the patients of Utah and the Mountain West.

And let’s not forget that we must train the next generation of clinicians and researchers to continue the search for cures in blood disorders. In our Division we strive to bring everything together: excellence in research, excellence in clinical care, and excellence in teaching.

Michael W. Deininger, MD, PhD